{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:59:48Z","timestamp":1792724388962,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.autrev.2011.03.004","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T01:39:39Z","timestamp":1301967579000},"page":"509-513","source":"Crossref","is-referenced-by-count":114,"title":["Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study"],"prefix":"10.1016","volume":"10","author":[{"given":"P.","family":"Ghillani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Toly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bengoufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nicaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Goulvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gleizes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Dragon-Durey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Alyanakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chollet-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Musset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Johanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.03.004_bb0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","article-title":"A 52-kD protein is a novel component of the SS-a\/Ro antigenic particle","volume":"167","author":"Ben Chetrit","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.03.004_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1172\/JCI115003","article-title":"Molecular definition and sequence motifs of the 52-kD component of human SS-A\/Ro autoantigen","volume":"87","author":"Chan","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.03.004_bb0020","first-page":"183","article-title":"The mapping of the human 52-kD Ro\/SSA autoantigen gene to human chromosome 11, and its polymorphisms","volume":"52","author":"Frank","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2011.03.004_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2567.2002.01417.x","article-title":"The 52000MW Ro\/SS-A autoantigen in Sj\u00f6gren's syndrome\/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures","volume":"106","author":"Rhodes","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2011.03.004_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2005.11.029","article-title":"Autoantigen Ro52 is an E3 ubiquitin ligase","volume":"339","author":"Wada","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2011.03.004_bb0035","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.molimm.2006.10.013","article-title":"TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain","volume":"44","author":"Rhodes","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0040","first-page":"145","article-title":"Extraordinary antigenicity of the human Ro52 autoantigen","volume":"2","author":"Burbelo","year":"2010","journal-title":"Am J Trans Res"},{"key":"10.1016\/j.autrev.2011.03.004_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.03.004_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0055","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro52 kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2011.03.004_bb0060","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2011.03.004_bb0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/rheumatology\/kep145","article-title":"Clinical significance of anti-Ro\/SSA-52kDa antibodies\u2014a retrospective monocentric study","volume":"48","author":"Hervier","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2011.03.004_bb0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jcp.2006.040360","article-title":"Specific testing for \u201cisolated\u201d anti-52kDa SSA\/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value","volume":"60","author":"Langguth","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1179\/acb.2009.049","article-title":"Detection and identification of antinuclear antibodies (AAN) in a large community hospital","volume":"64","author":"Verstegen","year":"2009","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.autrev.2011.03.004_bb0080","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.03.004_bb0090","doi-asserted-by":"crossref","unstructured":"Song JS, Do JH, Lee SW. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sj\u00f6gren's syndrome. Rheumatol Int 2011 (Jan 19, Electronic publication ahead of print).","DOI":"10.1007\/s00296-010-1790-x"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2011.03.004_bb0095","first-page":"250","article-title":"Antibody responses specific for soluble liver antigen co-occur with Ro52 autoantibodies in patients with autoimmune hepatitis","author":"Liaskos","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0100","first-page":"845","article-title":"Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro60, and anti-La in primary Sj\u00f6gren's syndrome","volume":"35","author":"Locht","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0105","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus. A prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0110","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","article-title":"Anti-SSA\/Ro52 antibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block","volume":"30","author":"Eftekhari","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0115","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar1848","article-title":"52-kDa Ro\/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block","volume":"8","author":"Fritsch","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.03.004_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amjcard.2010.10.059","article-title":"Spontaneous rupture of atrioventricular valve tensor apparates as late manifestation of Anti-Ro\/SSA antibody-mediated cardiac disease","volume":"107","author":"Cuneo","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0125","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sj\u00f6gren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0130","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/jid.2008.453","article-title":"High Ro52 expression in spontaneous and UV-induced cutaneous inflammation","volume":"129","author":"Oke","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncprheum0760","article-title":"Mechanisms of disease: autoantigen as clues to the pathogenesis of myositis","volume":"4","author":"Suber","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.autrev.2007.11.026","article-title":"Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response","volume":"7","author":"Gomez-Martin","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.03.004_bb0145","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"46","author":"Mallery","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.autrev.2011.03.004_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-6-2","article-title":"Prevalence of antibodies to Ro-52 in a serological defined population of patients with systemic sclerosis","volume":"6","author":"Parker","year":"2009","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.autrev.2011.03.004_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","article-title":"Diagnostic utility of anti-Ro52 detection in systemic autoimmunity","volume":"86","author":"Dugar","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.autrev.2011.03.004_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial Lung disease","volume":"39","author":"La Corte","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2011.03.004_bb0165","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/art.22790","article-title":"Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis","volume":"56","author":"Levine","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.03.004_bb0170","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lpm.2010.06.008","article-title":"How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies","volume":"39","author":"Sibilia","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2011.03.004_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10875-007-9157-0","article-title":"Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies","volume":"28","author":"Strandberg","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2011.03.004_bb0180","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"8","author":"Espinosa","year":"2009","journal-title":"J Exp Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T13:39:21Z","timestamp":1560087561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1568997211000589"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.03.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}